Deep Learning-Based Intraoperative Dual-tracer Video Analysis of Sentinel Lymph Node Mapping for Metastasis Prediction in cN0 Papillary Thyroid Carcinoma
NCT07391514 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 131
Last updated 2026-02-06
Summary
The goal of this observational study is to learn if a computer program (deep learning) can accurately predict lymph node spread in adults with papillary thyroid cancer who have no signs of lymph node involvement before surgery (called cN0). The main questions it aims to answer are:
* Can video analysis of lymph node mapping during surgery predict if cancer has spread to lymph nodes beyond the first-draining (sentinel) lymph node?
* Can this prediction help surgeons decide how much tissue to remove during surgery?
During surgery, participants will receive an injection of two special dyes (carbon nanoparticles and indocyanine green) near the thyroid tumor. These dyes travel through the lymphatic system and help surgeons see the lymph nodes. A special camera records a video of how the dyes move and light up the lymph nodes.
Researchers will use computer programs to analyze these videos along with other medical information (such as ultrasound results and tumor characteristics) to predict whether cancer has spread to additional lymph nodes. The predictions will be compared against the actual results from tissue samples examined after surgery.
Participants will receive standard thyroid cancer surgery. The study does not change the surgical treatment. The video recording adds no extra risk to participants.
Conditions
- Papillary Thyroid Carcinoma
Interventions
- DIAGNOSTIC_TEST
-
Indocyanine green (ICG) sentinel lymph node mapping
Intraoperative sentinel lymph node mapping using indocyanine green (ICG) with near-infrared fluorescence imaging. Preparation: ICG powder (25 mg) is dissolved in 10 ml sterile water to achieve a concentration of 2.5 mg/ml. Administration: 0.2 ml of ICG solution is injected at multiple points around the thyroid tumor under real-time ultrasound guidance using a precision multi-point stereotactic injection technique. Visualization: A near-infrared fluorescence imaging system (excitation wavelength 750-800 nm, emission wavelength 820 nm) is used to visualize lymphatic channels and identify sentinel lymph nodes in real time during surgery. The sentinel lymph node is defined as the first lymph node that shows fluorescence signal after tracer injection.
- DIAGNOSTIC_TEST
-
Carbon nanoparticle (CNs) sentinel lymph node mapping
Intraoperative sentinel lymph node mapping using carbon nanoparticle suspension with visual identification. Preparation: Carbon nanoparticle suspension is used at the commercial concentration of 50 mg/ml. Administration: 0.2 ml of carbon nanoparticle suspension is injected at multiple points around the thyroid tumor under real-time ultrasound guidance using a precision multi-point stereotactic injection technique. Visualization: Carbon nanoparticles (diameter 150 nm) selectively enter lymphatic channels and accumulate in lymph nodes, producing visible black staining. Surgeons identify sentinel lymph nodes by direct visual inspection of black-stained nodes. The sentinel lymph node is defined as the first lymph node that shows black staining after tracer injection.
- DIAGNOSTIC_TEST
-
Dual-tracer (ICG combined with CNs) sentinel lymph node mapping
Intraoperative sentinel lymph node mapping using combined indocyanine green and carbon nanoparticles with near-infrared fluorescence imaging and visual identification. Preparation: 0.1 ml of ICG solution (2.5 mg/ml) is mixed with 0.1 ml of carbon nanoparticle suspension (50 mg/ml) to form a 0.2 ml dual-tracer composite agent. Administration: The mixed tracer is injected at multiple points around the thyroid tumor under real-time ultrasound guidance using a precision multi-point stereotactic injection technique. Visualization: Near-infrared fluorescence imaging captures real-time lymphatic flow dynamics (ICG component), while black staining provides durable visual lymph node identification (CNs component). Video recording documents the entire sentinel lymph node visualization process for at least 5 minutes at 1920x1080 resolution. Deep learning analysis: In this group, video recordings are analyzed using nine deep learning models to extract spatiotemporal features and predict second
Sponsors & Collaborators
-
First Affiliated Hospital of Chongqing Medical University
lead OTHER
Principal Investigators
-
Xinliang Su, MD,PhD · First Affiliated Hospital of Chongqing Medical University
-
Han Gao, MD,PhD · Women and Children's Hospital of Chongqing Medical University
-
Xinliang Su, MD,PhD · First Affiliated Hospital of Chongqing Medical University
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-04-01
- Primary Completion
- 2024-10-31
- Completion
- 2024-10-31
Countries
- China
Study Locations
More Related Trials
-
Sentinel Lymph Node Biopsy With or Without Para-Sentinel Lymph Node Dissection in Breast Cancer
NCT02651142 ·Status: UNKNOWN ·Phase: NA
-
Sentinel Lymph Node Identification in the Axilla of Women With Breast Cancer Using Ultrasound and Iron Injection
NCT02610920 ·Status: WITHDRAWN ·Phase: EARLY_PHASE1
-
Selective Lymph Node Dissection Using Fluorescent Dye in Node-positive Breast Cancer
NCT02781259 ·Status: UNKNOWN ·Phase: PHASE4
-
Artificial Intelligence Analysis of Fluorescence Image to Intraoperatively Detect Metastatic Sentinel Lymph Node.
NCT05623280 ·Status: UNKNOWN
-
Photo-medicine-Guided Dual Approach for Reoperation of Sentinel Lymph Nodes in Locally Recurrent Breast Cancer Patients
NCT06780748 ·Status: RECRUITING ·Phase: PHASE2
-
Concurrent Use Lymphoseek & Indocyanine Green in Sentinel Lymph Node Detection in Endometrial Cancer
NCT04511026 ·Status: TERMINATED ·Phase: PHASE2
-
Computed Tomography (CT) Based Lymphatic Mapping and Localization of Sentinel Lymph Node in Breast Cancer Patients
NCT00952679 ·Status: UNKNOWN ·Phase: PHASE3
-
Prediction of Non-sentinel Lymph Node Metastatic Status of Breast Cancer Based on Pathology-MRI Images
NCT06510738 ·Status: NOT_YET_RECRUITING
-
Evaluation of an Integrated Imaging System For In Vivo Detection of Fluorescently Labeled Lesions
NCT02802553 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Comparison Study of Sentinel Lymph Node Biopsy by Multimodal Method in Breast Cancer
NCT01856452 ·Status: COMPLETED ·Phase: PHASE2
-
Clinical Application of Multi-modal Sentinel Lymph Node Staining Method in Breast Cancer Patients After Neoadjuvant Chemotherapy
NCT06212440 ·Status: COMPLETED ·Phase: NA
-
Deep Learning Algorithms for Prediction of Lymph Node Metastasis and Prognosis in Breast Cancer MRI Radiomics (RBC-01)
NCT04003558 ·Status: UNKNOWN
-
Predict the Risk of Axillary Metastases in Breast Cancer Patients With Axillary Ultrasound
NCT02992769 ·Status: UNKNOWN
-
Predictive MRI Metrics for Tumor Aggressiveness in Papillary Thyroid Cancer
NCT02178345 ·Status: COMPLETED
-
Radiological Prediction of Response to Neoadjuvant Chemoimmunotherapy for Triple-negative Breast Cancer
NCT06879704 ·Status: RECRUITING ·Phase: NA
-
Internal Mammary Sentinel Lymph Node Biopsy in Early Breast Cancer Patients With Clinically Axillary Node -Positive
NCT01668914 ·Status: COMPLETED ·Phase: PHASE3
-
ICG and SLN Mapping
NCT05859971 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Rapid Assessment of Sentinel Lymph Node Metastasis Status Using a Pan-CK-targeting NIR-II Fluorescent Probe in Breast Cancer
NCT07154563 ·Status: RECRUITING
-
Application of Surgical Navigation System in Sentinel Lymph Node of Breast Cancer Research
NCT02084784 ·Status: COMPLETED ·Phase: NA
-
MRI Radiomics Assessing Neoadjuvant Chemotherapy in Breast Cancer to Predict Lymph Node Metastasis and Prognosis(RBC-02)
NCT04004559 ·Status: UNKNOWN
-
Trop2-targeting NIR-II Molecular Probe for Breast Cancer Precise Surgery
NCT06713681 ·Status: COMPLETED
-
ICG Fluorescence Technique for the Detection of Sentinel Lymph Nodes
NCT01395706 ·Status: UNKNOWN ·Phase: PHASE2
-
Evaluation of Two New Medical Instruments Dedicated to the Sentinel Lymph Node Technique in Case of Breast Cancer
NCT00357487 ·Status: COMPLETED ·Phase: NA
-
Sentinel Lymph Node Biopsy in Breast Cancer Surgery Using ICG
NCT03579979 ·Status: COMPLETED ·Phase: NA
-
Internal Mammary Sentinel Lymph Node Biopsy in Early Breast Cancer Patients With Clinically Axillary Node -Negative
NCT01642511 ·Status: COMPLETED ·Phase: PHASE2